Search research articles
Contact Us
Filters
Showing results (561-570 of 724) with videos related to
Page
of 73
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2016
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
Noura J Choudhury, Alexa Campanile, Tatjana Antic, et al.
Leukemia
|
February 20, 2003
The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML
A Kaeferstein, U Krug, J Tiesmeier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2006
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study
Brian I Rini, Susan Halabi, Robert Barrier, et al.
Cancer
|
December 24, 2003
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma
Nicholas J Vogelzang, Theodore Karrison, Walter M Stadler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2011
A phase I study of sirolimus and bevacizumab in patients with advanced malignancies
E E W Cohen, M R Sharma, L Janisch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?
Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Urologic Oncology
|
October 7, 2004
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
Donald S Kaufman, Michael A Carducci, Tim M Kuzel, et al.
Gynecologic Oncology
|
April 22, 2008
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia
Halla S Nimeiri, Amit M Oza, Robert J Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583)
Eric J Small, Susan Halabi, Nancy A Dawson, et al.
The Open Allergy Journal
|
February 10, 2012
Anti-idiotypic Fab Fragments Image a Conserved N-terminal Epitope Patch of Grass Pollen Allergen Phl p 1
Anna Lukschal, Jan Fuhrmann, Juryj Sobanov, et al.
Page
of 73
Search research articles
Search
Showing results (561-570 of 724) with videos related to
Sort By:
Page
of 73
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 6, 2016
Afatinib Activity in Platinum-Refractory Metastatic Urothelial Carcinoma in Patients With ERBB Alterations
Noura J Choudhury, Alexa Campanile, Tatjana Antic, et al.
Leukemia
|
February 20, 2003
The emergence of a C/EBPalpha mutation in the clonal evolution of MDS towards secondary AML
A Kaeferstein, U Krug, J Tiesmeier, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
June 21, 2006
Adoptive immunotherapy by allogeneic stem cell transplantation for metastatic renal cell carcinoma: a CALGB intergroup phase II study
Brian I Rini, Susan Halabi, Robert Barrier, et al.
Cancer
|
December 24, 2003
A Phase II trial of suramin monthly x 3 for hormone-refractory prostate carcinoma
Nicholas J Vogelzang, Theodore Karrison, Walter M Stadler, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2011
A phase I study of sirolimus and bevacizumab in patients with advanced malignancies
E E W Cohen, M R Sharma, L Janisch, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2007
Recommended changes to oncology clinical trial design: revolution or evolution?
Mark J Ratain, Rachel W Humphrey, Gary B Gordon, et al.
Urologic Oncology
|
October 7, 2004
A multi-institutional phase II trial of gemcitabine plus paclitaxel in patients with locally advanced or metastatic urothelial cancer
Donald S Kaufman, Michael A Carducci, Tim M Kuzel, et al.
Gynecologic Oncology
|
April 22, 2008
Efficacy and safety of bevacizumab plus erlotinib for patients with recurrent ovarian, primary peritoneal, and fallopian tube cancer: a trial of the Chicago, PMH, and California Phase II Consortia
Halla S Nimeiri, Amit M Oza, Robert J Morgan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 17, 2004
Antiandrogen withdrawal alone or in combination with ketoconazole in androgen-independent prostate cancer patients: a phase III trial (CALGB 9583)
Eric J Small, Susan Halabi, Nancy A Dawson, et al.
The Open Allergy Journal
|
February 10, 2012
Anti-idiotypic Fab Fragments Image a Conserved N-terminal Epitope Patch of Grass Pollen Allergen Phl p 1
Anna Lukschal, Jan Fuhrmann, Juryj Sobanov, et al.
Page
of 73